KYNB

Kyntra Bio, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Wettig ThaneDirector, Officer: CEO
$20k2.8k shares
BuyMay 14, 2026
$7.09
--
Wettig ThaneDirector, Officer: CEO
$20k2.8k shares
BuyMay 14, 2026
$7.09
--
Wettig ThaneDirector, Officer: CEO
$25k2.7k shares
BuyNov 17, 2025
$9.10
--
Wettig ThaneDirector, Officer: CEO
$9.2k1k shares
BuyNov 13, 2025
$9.18
--
Schoeneck James ADirector
$119k23.6k shares
BuyJun 30, 2025
$5.07
--
Wettig ThaneDirector, Officer: CEO
$51k145k shares
BuyMar 24, 2025
$0.3494
--

News

globenewswire.comKyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromesglobenewswire.comJun 11seekingalpha.comKyntra Bio, Inc. (KYNB) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 11zacks.comKyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimateszacks.comMay 11globenewswire.comKyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Updateglobenewswire.comMay 11globenewswire.comKyntra Bio to Report First Quarter 2026 Financial Resultsglobenewswire.comMay 4